Peter Keeling interview: Owning the diagnostic journey

Peter Keeling of medical technology firm Diaceutics tells Pádraig Hoare why hundreds of thousands of patients could be missing out on life-saving drugs and how he hopes to change it.

For Peter Keeling, the boss of medtech firm Diaceutics, the mission is simple: Make it easier for laboratories, doctors, diagnostic and pharmaceutical companies to work more closely together so that patients with cancer and other life-threatening diseases get the best chance of recovery.

It seems obvious to a layperson, but according to the founder of the Dundalk-based company, there has historically been a lack of that co-ordinated approach, meaning hundreds of thousands of patients are missing out on the specific drugs that could mean the difference between life and death.